News & Updates
Filter by Specialty:
Postpartum depression: Another outcome of the COVID-19 pandemic?
Several studies presented at ACOG 2022 have raised the question as to whether postpartum depression (PPD) is one of the mental health outcomes of the COVID-19 pandemic.
Postpartum depression: Another outcome of the COVID-19 pandemic?
08 Jun 2022
Ixa-dex, pom-dex both effective in heavily pretreated relapsed, refractory multiple myeloma
Ixazomib-dexamethasone (ixa-dex) and pomalidomide-dexamethasone (pom-dex) achieve comparable levels of efficacy and safety in relapsed and refractory multiple myeloma (RRMM) patients who had already been exposed to prior lenalidomide-based regimens, a recent study has found.
Ixa-dex, pom-dex both effective in heavily pretreated relapsed, refractory multiple myeloma
08 Jun 2022
ECT-induced negative symptom improvements boost cognition, functioning in schizophrenia
Electroconvulsive therapy (ECT) or the delivery of a finely controlled electric current to the brain in patients with schizophrenia can effectively address negative symptoms, which in turn translates to improvements in overall function, as shown in a study from Singapore.
ECT-induced negative symptom improvements boost cognition, functioning in schizophrenia
08 Jun 2022
Hepatitis E virus resistant to most alcohol-based disinfectants
Alcohols and alcohol-based disinfectants are not strong enough to eliminate the hepatitis E virus (HEV), except for one commercial ethanol-based product that has phosphoric acid, a study has shown. This finding may help develop measures to reduce transmission in clinical practice.
Hepatitis E virus resistant to most alcohol-based disinfectants
08 Jun 2022
Antihypertensive drug does not lower death risk in HFrEF patients
Use of an antihypertensive drug does not appear to reduce the risk of all-cause mortality or hospital readmission in hospitalized older patients with heart failure with reduced ejection fraction (HFrEF) who are receiving contemporary treatments for HF, reveals a recent study.